论文部分内容阅读
目的探讨糖化血红蛋白检验在糖尿病诊治中的应用。方法选取46例糖尿病患者作为观察组,另选46例体检中心健康人群作为对照组,对两组进行糖化血红蛋白检验,同时进行空腹血糖的测定,观察两组糖化血红蛋白、空腹血糖水平,并进行比较。结果观察组空腹血糖水平为(9.51±3.11)mmol/L、糖化血红蛋白水平为(9.16±1.60)%,对照组空腹血糖水平为(4.61±0.80)mmol/L、糖化血红蛋白水平为(4.61±0.70)%,观察组糖化血红蛋白及空腹血糖水平均明显高于对照组,差异均具有统计学意义(P<0.05)。结论糖化血红蛋白水平可以体现出人体6~8周的水平,在糖尿病的诊治过程中具有参考价值,同时对于糖尿病治疗过程中血糖控制情况同样具有参考意义,可在临床检查中进行普及。
Objective To investigate the application of glycosylated hemoglobin test in the diagnosis and treatment of diabetes mellitus. Methods Forty-six patients with diabetes mellitus were selected as the observation group and 46 healthy people from the physical examination center were selected as the control group. HbA1c and HbA1c were measured in both groups. HbA1c and fasting blood glucose levels were observed and compared . Results The fasting blood glucose of the observation group was (9.51 ± 3.11) mmol / L, the level of glycosylated hemoglobin was (9.16 ± 1.60)%, the fasting blood glucose level was (4.61 ± 0.80) mmol / L and the level of glycosylated hemoglobin was (4.61 ± 0.70) )%, HbA1c and fasting blood glucose in the observation group were significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusions HbA1c can reflect the level of 6 ~ 8 weeks in human body and has reference value in the diagnosis and treatment of diabetes mellitus. At the same time, it also has reference meaning for the control of blood sugar in the course of diabetes mellitus, which can be popularized in clinical examination.